Eco R1 Capital, LLC Ac Immune Sa Transaction History

Eco R1 Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.35 - $4.47 $1.14 Million - $2.17 Million	-485,005 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.5 - $5.16 $926,030 - $1.37 Million	-264,580 Reduced 35.3%	485,005 $1.94 Million
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $8,046 - $12,594	-1,666 Reduced 0.22%	749,585 $3.71 Million
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $11.8 Million - $15.8 Million	-1,896,912 Reduced 71.63%	751,251 $5.04 Million
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $6.04 Million - $8.37 Million	-1,000,000 Reduced 27.41%	2,648,163 $21 Million
Q1 2021 May 17, 2021	BUY	$5.32 - $8.96 $6.59 Million - $11.1 Million	1,237,923 Added 51.36%	3,648,163 $27.8 Million
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $10.8 Million - $13.4 Million	2,410,240 New	2,410,240 $12.5 Million

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $224M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.